[1]
Lepedda, A.J., Deiana, G.A., Lobina, O., Nieddu, G., Baldinu, P., De Muro, P., Andreetta, F., Sechi, E., Arru, G., Corda, D.G., Sechi, G.P. and Formato, M. 2019. Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential. Journal of Circulating Biomarkers. 8, 1 (Sep. 2019). DOI:https://doi.org/10.33393/jcb.2019.2098.